Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps she is taking to ensure that men who have taken Sodium Valproate receive compensation for (a) fertility and (b) other health effect.
Our sympathies remain with those affected by sodium valproate. The Government is carefully considering the Patient Safety Commissioner’s recommendations as set out in the Hughes Report: Options for redress for those harmed by valproate and pelvic mesh, published on 7 February 2024, and will respond substantively in due course.
As part of the Medicines and Healthcare products Regulatory Agency’s ongoing monitoring of valproate safety, we continue to rigorously review all emerging data on valproate.